
Strategic Report Corporate Governance Financial Statements 131
EUROWAG Annual Report and Accounts 2023
Key audit matter How our audit addressed the key audit matter
Presentation of adjusting items
to EBITDA (group)
As at 31 December 2023, certain costs have been
classified as adjusting items impacting adjusted
EBITDA and certain other costs have been classified
as adjusting items impacting adjusted earnings for
the year.
The adjusting items impacting adjusted EBITDA
relate to: M&A related expenses; strategic
transformation expenses; share based
compensation; impairment losses of non-financial
assets and restructuring costs.
The adjusting items impacting adjusted earnings
relate to amortisation of acquired intangibles, offset
by a tax effect of adjusting items.
We focused on this area as there is no definition of
an adjusting item within IFRS and so judgement is
required by the directors in determining whether
items classified as adjusting are consistent with the
group’s accounting policy.
We also focussed on this area given the potential
fraud risk attached to the presentation of these
items in meeting market consensus and profit based
personal incentive targets.
Refer to the Notes 6 and 11 to the financial
statements and the Key accounting issues,
significant judgements and significant estimates
section of the Audit and Risk Committee report.
We have considered the nature of the balances and
challenged the directors as to whether the items
disclosed as adjusting items are consistent with the
accounting policy, with the approach taken in previous
reporting periods and with the FRC’s guidance.
We evaluated and understood the rationale behind each
adjusting item and audited each category of adjusting
items to EBITDA to a specific materiality of EUR 1.0m.
This involved agreeing the sampled items to underlying
supporting documentation and assessing whether the
treatment of the item as adjusting was consistent with
the group’s accounting policy.
For amortisation of acquired intangibles we have target
tested these expenses and assessed whether the
treatment of each item as adjusting was consistent
with the group’s accounting policy.
We have also challenged the disclosures included in
the Notes to the financial statements to assess whether
they were clear and balanced.
Based on our procedures, the presentation and
disclosure of adjusting items is consistent with the
evidence obtained.
Valuation of the acquired Inelo
intangibles (group)
On 15 March 2023 the group acquired 100% of the
share capital of Grupa Inelo S.A (“Inelo”).
In accordance with IFRS 3, the directors are required
to perform an exercise to determine the fair values of
the identifiable assets acquired and liabilities
assumed at the date of acquisition, which has
resulted in the recognition of intangible assets and
associated goodwill alongside the net assets of
Inelo.
We focused on this area because the valuation of
intangible assets requires the directors to exercise
judgement in generating the fair value of these
assets, as it is derived from models which include
subjective assumptions and cash flow estimates.
Refer to the Notes 6 and 8 to the financial
statements and the Key accounting issues,
significant judgements and significant estimates
section of the Audit and Risk Committee report.
As part of our audit of the directors’ fair value exercise
and the associated intangible valuations models:
@
We validated that the methodology applied to value
each individual intangible asset was reasonable and
in line with market practice.
@
We tested the fair value ascribed to intangible assets
by understanding the assumptions adopted, which
primarily include the cash flow forecasts, customer
attrition and discount rates.
@
We obtained evidence to evaluate the key
assumptions underpinning the cash flow forecasts,
including considering the existence of contradictory
evidence.
@
We used our internal valuation experts to determine
that the assumptions on discount rate and attrition
rates were reasonable, through reference to suitable
third-party comparator information.
@
We audited the disclosures related to business
combinations to ensure these were consistent with
the requirements of IFRS 3.
Based on our procedures, the valuation of intangible
assets relating to the Inelo business and the disclosures
included in the financial statements are consistent with
the evidence obtained.
Key audit matter How our audit addressed the key audit matter
Impairment of goodwill within the Fleet
Management Solutions CGU (group)
In accordance with IAS 36 (Impairment of assets),
goodwill must be tested for impairment on at least an
annual basis. The determination of recoverable
amount, being the higher of value-in-use and fair
value less costs of disposal, requires estimation by
the directors to value the relevant CGU.
The directors have charged an impairment to
goodwill in the year to the Fleet Management
Solutions (“FMS”) CGU, due to a reduction in the
cash flows expected to be generated from the CGU.
The impairment charge has been reported as an
adjusting item to EBITDA.
We focused on the risk of impairment within the FMS
CGU as the impairment test involves several
subjective estimates by the directors. These
estimates include key assumptions in relation to the
future cash flows of the CGU, including considering
the impact of climate change, and the level of
synergies expected to be realised following the
acquisition of Inelo.
Refer to the Notes 6 and 19 to the financial
statements and the Key accounting issues,
significant judgements and significant estimates
section of the Audit and Risk Committee report.
As part of our audit of the directors’ impairment
assessment and underlying discounted cash flow
model:
@
We obtained and audited the impairment model
which calculates the value-in-use based on five year
forecast cash flows.
@
We identified the key assumptions within the cash
flow forecast for the next five years and focused our
work on these. We verified these cash flows to
underlying support, including Board approved
budgets and third-party market forecast data. We
challenged the basis of the forecasts to validate that
all key assumptions were supportable and that the
cash flows reflected the CGUs current strategic plan,
including the integration activities within the Inelo
business and the resultant realisation of synergy
benefits. We also challenged the potential impact of
climate change to the cash flow forecast, ensuring
this was consistent with the assessment performed
within the TCFD disclosures.
@
We used our internal valuation experts to determine
that the discount rate and growth rate were within an
acceptable range through reference to suitable
third-party comparator information.
@
We obtained the assessment of the fair value less
costs of disposal of the CGU and evaluated the
reasonableness of the assumptions applied,
specifically the estimated costs of disposal and
EBITDA multiple through the use of our internal
valuation experts.
@
We evaluated the disclosures included in the
financial statements, including the sensitivity
analysis, to validate that these were in compliance
with IAS 36.
Based on our procedures, the impairment charge
recognised and the disclosures included in the financial
statements are consistent with the evidence obtained.
Carrying value of investment in subsidiaries
(parent)
Investment in subsidiaries are accounted for in the
Company balance sheet at cost less provision for
impairment. Investments are tested for impairment if
impairment indicators exist. If such indicators exist,
the recoverable amounts of the investments in
subsidiaries are estimated in order to determine the
extent of the impairment loss, if any. Any such
impairment loss is recognised in the income
statement.
A review for indicators of impairment was performed
by the directors, including considering the latest
available forecasts and developments in the Group
during the year. The assessment identified no
impairment indicator in respect of the investments in
subsidiaries.
Refer to the Note 6 to the company financial
statements.
We evaluated the directors’ determination of whether
there were any other indicators of impairment. Our
procedures included:
@
comparing the carrying value of investment with the
market capitalisation of the Group at 31 December
2023; and
@
comparing the carrying value of investment with the
carrying amount of investees’ net assets.
Overall, we found the assessment of the carrying value
of investment in subsidiaries and associated
disclosures to be consistent with the evidence
obtained.